'Super Office' To The Rescue: FDA's Device Center Is About To Undergo A 'Total Product Life Cycle' Makeover

CDRH Director Jeff Shuren told industry that the device center is moving quickly to establish a "super office" to tackle the full spectrum of pre- and post-market issues to reduce inefficiencies to replace the more siloed approach. Chief Scientist Bill Maisel has already been named a director.

Jeff Shuren
CDRH Director Jeff Shuren took industry questions at AdvaMed's Medtech Conference 2017 FDA town hall • Source: Ferdous Al-Faruque

US FDA's device center is moving quickly on a major reorganization that will essentially dissolve and replace the Office of Compliance, Office of Surveillance and Biometrics, and Office of Device Evaluation into one "super office" that would fulfill a "Total Product Life Cycle" (TPLC) scheme the agency has long envisioned.

The yet-unnamed office would have jurisdiction not just to review and greenlight products in the pre-market stage, but continue to...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation